In 2015 alone, more than 21,000 women will receive a diagnosis of ovarian cancer and approximately 14,000 women will die of the disease. Often diagnosed at advanced stages, ovarian cancer is aggressive and particularly tough to treat.
Last month, Roswell Park made headlines around the world with the announcement that we expect to be the first U.S. institution to offer a lung cancer treatment vaccine developed by the Center for Molecular Immunology in Cuba.
Immunotherapy—using the power of the immune system to fight cancer—is a hot topic in scientific research, so much so that it has earned its own month. June is recognized as Immunotherapy Awareness Month.
As Immunotherapy Awareness Month winds down, we want to highlight three different clinical trials being led by physicians at our Center for Immunotherapy of novel immunotherapy approaches for treating genitourinary cancers.